Disparities in clinical trial participation among older adults with multiple myeloma in the United States

被引：2

作者：

White, Priscila ^{[1
,2
]}

Cooley, Abigail ^{[1
,2
]}

Bal, Susan ^{[3
]}

Godby, Kelly ^{[3
]}

Ravi, Gayathri

Clark, Deanna ^{[2
]}

Ubersax, Clare ^{[2
]}

Williams, Grant R. ^{[2
,3
]}

Costa, Luciano J. ^{[3
]}

Giri, Smith ^{[2
,3
]}

机构：

[1] Univ Alabama Birmingham, Heersink Sch Med, Birmingham, AL USA

[2] Univ Alabama Birmingham, Inst Canc Outcomes & Survivorship, Div Hematol & Oncol, Birmingham, AL USA

[3] Univ Alabama Birmingham, Div Hematol & Oncol, Dept Med, ONeal Comprehens Canc Ctr, Birmingham, AL 35233 USA

来源：

JOURNAL OF GERIATRIC ONCOLOGY | 2022年 / 13卷 / 08期

关键词：

Multiple myeloma; Clinical trial participation; Older adults; Clinical trial disparities; Representation in clinical trials; RACE; AGE;

D O I：

10.1016/j.jgo.2022.07.001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1241 / 1243

页数：3

共 15 条

[1]

Bhatnagar V, 2017, BLOOD, V130

[2]

Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986

[3] Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States [J].

Costa, Luciano J. ;

Brill, Ilene K. ;

Omel, James ;

Godby, Kelly ;

Kumar, Shaji K. ;

Brown, Elizabeth E. .

BLOOD ADVANCES, 2017, 1 (04) :282-287

[4] Differences between unselected patients and participants in multiple myeloma clinical trials in US: a threat to external validity [J].

Costa, Luciano J. ;

Hari, Parameswaran N. ;

Kumar, Shaji K. .

LEUKEMIA & LYMPHOMA, 2016, 57 (12) :2827-2832

[5] Frontline treatment patterns and attrition rates by subsequent lines of therapy in patients with newly diagnosed multiple myeloma [J].

Fonseca, Rafael ;

Usmani, Saad Z. ;

Mehra, Maneesha ;

Slavcev, Mary ;

He, Jianming ;

Cote, Sarah ;

Lam, Annette ;

Ukropec, Jon ;

Maiese, Eric M. ;

Nair, Sandhya ;

Potluri, Ravi ;

Voorhees, Peter M. .

BMC CANCER, 2020, 20 (01)

[6] Real-world applicability of commercial chimeric antigen receptor T-cell therapy among older adults with relapsed and/or refractory multiple myeloma [J].

Giri, Smith ;

Bal, Susan ;

Godby, Kelly N. ;

Ravi, Gayathri ;

Clark, Deanna ;

Ubersax, Clare ;

Cooley, Abigail ;

White, Priscila ;

Rangarajan, Sunil ;

Williams, Grant R. ;

Costa, Luciano J. .

AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (04) :E153-E155

[7] Randomised controlled trials - the gold standard for effectiveness research Study design: randomised controlled trials [J].

Hariton, Eduardo ;

Locascio, Joseph J. .

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2018, 125 (13) :1716-1716

[8]

Institute N.C., 2021, SEER CANC STAT FACTS

[9]

Kanapuru B, 2017, BLOOD, V130

[10] Participation in cancer clinical trials - Race-, sex-, and age-based disparities [J].

Murthy, VH ;

Krumholz, HM ;

Gross, CP .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (22) :2720-2726

← 1 2 →